4D Molecular Therapeutics, Inc. · NASDAQ:FDMT

State Street Corp's stake in 4D Molecular Therapeutics, Inc. fell to 4.50% (Schedule 13G)

Event Sep 30, 2026 · Filed Nov 10, 2026

State Street Corp's stake in 4D Molecular Therapeutics, Inc. fell to 4.50%, 2,469,425 shares, as a passive investor on Sep 30, 2026. Filed Nov 10, 2026 (Schedule 13G).

Stake
4.50%
Shares
2,469,425
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
STATE STREET CORPORATION4.50%2,469,425

Source

Download original · View original at SEC

Related